Azelis to acquire S&D Group Ltd, UK

Joris Coppye, CEO, Azelis.

ANTWERP, BELGIUM: Azelis has agreed to acquire S&D Group Ltd in a bid to strengthen its life science business (pharma, food & health and personal care), both in terms of portfolio coverage as well as geographic spread. “The acquisition will give Azelis a leading position in personal care and pharma in the CEE region, including the CIS countries. Furthermore it will support the consolidation of our Indian distribution business (mainly chemicals and plastic polymers) with the addition of life science activities. In China we will be able to complement our existing sourcing operations with distribution activities. Last but not least the acquisition of S&D is an important step change towards globalisation through the access to new markets such as Canada, Australia, Middle East and Africa,” informed Joris Coppye, CEO, Azelis.

Excluded from the acquisition are those S&D companies involved in the pharmaceutical finished dosage (S&D pharma), chemical synthesis and laboratory supply markets (Chemgo), as well as part of its personal care actives business  (S&D Chesham GmbH and ProTec Ingredia) - these entities will retain their original ownership. The acquisition is expected to close within the first quarter.